Host-parasite interactions in trypanosomiasis: On the way to an antidisease strategy

Infection and Immunity

Volumn 77, Issue 4, 2009, Pages 1276-1284

  Antoine Moussiaux, Nicolas ^a   Biischer, Philippe ^b   Desmecht, Daniel ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

5 OXOPROLYL PEPTIDASE; ADALIMUMAB; COMPLEMENT; CYSTYL AMINOPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ETANERCEPT; GAMMA INTERFERON; HEPARIN; INFLIXIMAB; INOSITOL PHOSPHATE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MEMBRANE PROTEIN; NITRIC OXIDE; OLIGOPEPTIDE; PHOSPHOLIPASE C; PROTEIN INHIBITOR; PROTEIN P75; PROTOZOAL PROTEIN; RECOMBINANT ERYTHROPOIETIN; SIALIDASE; TRANSFORMING GROWTH FACTOR BETA1; TRYPANOSOMA VACCINE; TRYPANOSOME LYMPHOCYTE TRIGGERING FACTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VARIABLE SURFACE GLYCOPROTEIN; VASCULAR CELL ADHESION MOLECULE 1; ANTIPROTOZOAL AGENT;

AFRICAN TRYPANOSOMIASIS; ANEMIA; APOPTOSIS; B LYMPHOCYTE ACTIVATION; BLOOD BRAIN BARRIER; BLOOD PH; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL TRIAL; COMPARATIVE STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG INDICATION; GENOME; GLOSSINA; HOST PARASITE INTERACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFECTION PREVENTION; LEISHMANIASIS; LYMPHOCYTOPENIA; MACROPHAGE; MALARIA; MEMBRANE PERMEABILITY; PARASITE INCIDENCE; PARASITE PREVALENCE; PARASITE TRANSMISSION; PARASITE VECTOR; PARASITE VIRULENCE; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; THROMBOCYTOPENIA; TREATMENT INDICATION; TRYPANOSOMA BRUCEI; TRYPANOSOMA CONGOLENSE; TRYPANOSOMA EVANSI; TRYPANOSOMA VIVAX; VACCINATION; VACCINE PRODUCTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CATTLE; CLASSIFICATION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; MOUSE; PARASITOLOGY; PHYSIOLOGY; REVIEW; TRYPANOSOMA CRUZI;

ANIMALS; ANTIPROTOZOAL AGENTS; CATTLE; DRUG RESISTANCE; FEMALE; HOST-PARASITE INTERACTIONS; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS, AFRICAN;

EID: 63149182113     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01185-08     Document Type: Short Survey

References (163)

1. Abrahamson, M., M. Alvarez-Fernandez, and C. Nathanson. 2003. Cyst- atins. Biochem. Soc. Symp. 2003:179-199.
2. Anonymous. 2005. Human African trypanosomiasis. Seventeenth Program Report of the UNICEF/UNDP/World Bank/WHO Special Program for Research & Training in Tropical Diseases: making health research for poor people, progress 2003-2004. WHO, Geneva, Switzerland.
3. Anosa, V., and T. Isoun. 1976. Serum proteins, blood and plasma volumes in experimental Trypanosoma vivax infections of sheep and goats. Trop. Anim. Health Prod. 8:14-19.
4. Antoine-Moussiaux, N., S. Magez, and D. Desmecht. 2008. Contributions of the mouse model to understanding African trypanosomiasis. Trends Para- sitol. 24:411-418.
5. Assoku, R., and P. Gardiner. 1989. Detection of antibodies to platelets and erythrocytes during infection with haemorrhage-causing Trypanosoma vivax in Ayrshire cattle. Vet. Parasitol. 31:199-216.
6. Atwood, J. R., D. Weatherly, T. Minning, B. Bundy, C. Cavola, F. Opper-does, R. Orlando, and R. Tarleton. 2005. The Trypanosoma cruzi pro- teome. Science 309:473-476.
7. Authié, E., A. Boulangé, D. Muteti, G. Lalmanach, F. Gauthier, and A. Musoke. 2001. Immunisation of cattle with cysteine proteinases of Trypanosoma congolense: targetting the disease rather than the parasite. Int. J. Parasitol. 31:1429-1433.
8. Authie, E., D. Muteti, Z. Mbawa, J. Lonsdale-Eccles, P. Webster, and C. Wells. 1992. Identification of a 33-kilodalton immunodominant antigen of Trypanosoma congolense as a cysteine protease. Mol. Biochem. Parasitol. 56:103-116.
9. Baetselier, P., B. Namangala, W. Noël, L. Brys, E. Pays, and A. Beschin. 2001. Alternative versus classical macrophage activation during experimental African trypanosomosis. Int. J. Parasitol. 31:575-587.
10. Bakhiet, M., P. Büscher, R. Harris, K. Kristensson, H. Wigzell, and T. Olsson. 1996. Different trypanozoan species possess CD8 dependent lymphocyte triggering factor-like activity. Immunol. Lett. 50:71-80.
11. + lymphocytes to interferon-gamma secretion: purification, characterization and protective effects in vivo by treatment with a monoclonal antibody against the factor. Scand. J. Immunol. 37:165-178.
12. Balaban, N., H. Waithaka, A. Njogu, and R. Goldman. 1995. Intracellular antigens (microtubule-associated protein copurified with glycosomal enzymes)-possible vaccines against trypanosomiasis. J. Infect. Dis. 172:845850.
13. Banks, K. 1979. In vitro binding of Trypanosoma congolense to erythro-cytes. J. Protozool. 26:103-108.
14. Banks, K. 1980. Injury induced by Trypanosoma congolense adhesion to cell membranes. J. Parasitol. 66:34-37.
15. Baral, T., P. De Baetselier, F. Brombacher, and S. Magez. 2007. Control of Trypanosoma evansi infection is IgM mediated and does not require a type I inflammatory response. J. Infect. Dis. 195:1513-1520.
16. Beucher, M., and K. Norris. 2008. Sequence diversity of the Trypanosoma cruzi complement regulatory protein family. Infect. Immun. 76:750-758.
17. Bisalla, M., N. D. G. Ibrahim, I. A. Lawal, and K. A. N. Esievo. 2007. Serum total proteins, albumin and albumin globulin ratio in Yankasa sheep experimentally infected with Trypanosoma congolense and immunomodu- lated with levamisole. J. Protozool. Res. 17:39-43.
18. Bisser, S., O. Ouwe-Missi-Oukem-Boyer, F. Toure, Z. Taoufiq, B. Bouteille, A. Buguet, and D. Mazier. 2006. Harbouring in the brain: a focus on immune evasion mechanisms and their deleterious effects in malaria and human African trypanosomiasis. Int. J. Parasitol. 36:529-540.
19. Biswas, D., A. Choudhury, and K. Misra. 2001. Histopathologyof Trypano- soma (Trypanozoon) evansi infection in bandicoot rat. I. Visceral organs. Exp. Parasitol. 99:148-159.
20. Borges, M., A. Cordeiro-da-Silva, B. Vergnes, D. Sereno, and A. Ouaissi. 2005. Conversion of Trypanosoma cruzi Tc52 released factor to a protein inducing apoptosis. Tissue Cell 37:469-478.
21. Borges, M., A. Da Silva, D. Sereno, and A. Ouaissi. 2003. Peptide-based analysis of the amino acid sequence important to the immunoregulatory function of Trypanosoma cruzi Tc52 virulence factor. Immunology 109: 147-155.
22. Boulangé, A., C. Serveau, M. Brillard, C. Minet, F. Gauthier, A. Diallo, G. Lalmanach, and E. Authié. 2001. Functional expression of the catalytic domains of two cysteine proteinases from Trypanosoma congolense. Int. J. Parasitol. 31:1435-1440.
23. Brenchley, R., H. Tariq, H. McElhinney, B. Szöor, J. Huxley-Jones, R. Stevens, K. Matthews, and L. Tabernero. 2007. The TriTryp phosphatome: analysis of the protein phosphatase catalytic domains. BMC Genomics 8:434.
24. Bridges, D., A. Pitt, O. Hanrahan, K. Brennan, H. Voorheis, P. Herzyk, H. de Koning, and R. Burchmore. 2008. Characterisation of the plasma membrane subproteome of bloodstream form Trypanosoma brucei. Proteomics 8:83-99.
25. Broadhead, R., H. Dawe, H. Farr, S. Griffiths, S. Hart, N. Portman, M. Shaw, M. Ginger, S. Gaskell, P. McKean, and K. Gull. 2006. Flagellar motility is required for the viability of the bloodstream trypanosome. Nature 440:224-227.
26. Buratai, L., A. Nok, S. Ibrahim, I. Umar, and K. Esievo. 2006. Characterization of sialidase from bloodstream forms of Trypanosoma vivax. Cell Biochem. Funct. 24:71-77.
27. + B lym- phocytes are the main source of antibodies reactive with non-parasite antigens in Trypanosoma congolense-infected cattle. Immunology 92:226233.
28. Caffrey, C., E. Hansell, K. Lucas, L. Brinen, A. Alvarez Hernandez, J. Cheng, S. N. Gwaltney, W. Roush, Y. Stierhof, M. Bogyo, D. Steverding, and J. McKerrow. 2001. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 118:61-73.
29. Caffrey, C., S. Scory, and D. Steverding. 2000. Cysteine proteinases of trypanosome parasites: novel targets for chemotherapy. Curr. Drug Targets 1:155-162.
30. Cazorla, S., P. Becker, F. Frank, T. Ebensen, M. Sartori, R. Corral, E. Malchiodi, and C. Guzmán. 2008. Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi. Infect. Immun. 76:324-333.
31. Cunningham, D., T. Brewer, R. Kuhn, and W. Craig. 1981. Partial characterization of a Trypanosoma cruzi-released decomplementing factor. J. Parasitol. 67:475-480.
32. Darji, A., A. Beschin, M. Sileghem, H. Heremans, L. Brys, and P. De Baetselier. 1996. In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression. Infect. Immun. 64:1937-1943.
33. Davis, C. 1982. Thrombocytopenia: a uniform complication of African trypanosomiasis. Acta Trop. 39:123-133.
34. Desai, P., A. Patny, J. Gut, P. Rosenthal, B. Tekwani, A. Srivastava, and M. Avery. 2006. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory. J. Med. Chem. 49:1576-1584.
35. Desai, P., A. Patny, Y. Sabnis, B. Tekwani, J. Gut, P. Rosenthal, A. Srivastava, and M. Avery. 2004. Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database. J. Med. Chem. 47:6609-6615.
36. DosReis, G., C. Freire-de-Lima, M. Nunes, and M. Lopes. 2005. The importance of aberrant T-cell responses in Chagas disease. Trends Parasitol. 21:237-243.
37. El-Sayed, N., and J. Donelson. 1997. African trypanosomes have differentially expressed genes encoding homologues of the Leishmania GP63 surface protease. J. Biol. Chem. 272:26742-26748.
38. El-Sayed, N., P. Myler, G. Blandin, M. Berriman, J. Crabtree, G. Aggarwal, E. Caler, H. Renauld, E. Worthey, C. Hertz-Fowler, E. Ghedin, C. Peacock, D. Bartholomeu, B. Haas, A. Tran, J. Wortman, U. Alsmark, S. Angiuoli, A. Anupama, J. Badger, F. Bringaud, E. Cadag, J. Carlton, G. Cerqueira, T. Creasy, A. Delcher, A. Djikeng, T. Embley, C. Hauser, A. Ivens, S. Kum- merfeld, J. Pereira-Leal, D. Nilsson, J. Peterson, S. Salzberg, J. Shallom, J. Silva, J. Sundaram, S. Westenberger, O. White, S. Melville, J. Donelson, B. Andersson, K. Stuart, and N. Hall. 2005. Comparative genomics of trypanosomatid parasitic protozoa. Science 309:404-409.
39. Esievo, K., and D. Saror. 1983. Leukocyte response in experimental Trypanosoma vivax infection in cattle. J. Comp. Pathol. 93:165-169.
40. Esievo, K., D. Saror, A. Ilemobade, and M. Hallaway. 1982. Variation in erythrocyte surface and free serum sialic acid concentrations during experimental Trypanosoma vivax infection in cattle. Res. Vet. Sci. 32:1-5.
41. Ferreira, V., M. Molina, W. Schwaeble, D. Lemus, and A. Ferreira. 2005. Does Trypanosoma cruzi calreticulin modulate the complement system and angiogenesis? Trends Parasitol. 21:169-174.
42. Fish, W., Z. Nkhungulu, C. Muriuki, D. Ndegwa, J. Lonsdale-Eccles, and J. Steyaert. 1995. Primarystructure and partial characterization ofa life-cycle- regulated cysteine protease from Trypanosoma (Nannomonas) congolense. Gene 161:125-128.
43. Gao, W., H. Wortis, and M. Pereira. 2002. The Trypanosoma cruzi trans- sialidase is a T cell-independent B cell mitogen and an inducer of nonspecific Ig secretion. Int. Immunol. 14:299-308.
44. Gardiner, P., R. Assoku, D. Whitelaw, and M. Murray. 1989. Haemorrhagic lesions resulting from Trypanosoma vivax infection in Ayrshire cattle. Vet. Parasitol. 31:187-197.
45. Reference deleted.
46. Girard, M., S. Bisser, B. Courtioux, C. Vermot-Desroches, B. Bouteille, J. Wijdenes, J. Preud'homme, and M. Jauberteau. 2003. In vitro induction of microglial and endothelial cell apoptosis by cerebrospinal fluids from patients with human African trypanosomiasis. Int. J. Parasitol. 33:713-720.
47. Girard, M., S. Giraud, B. Courtioux, M. Jauberteau-Marchan, and B. Bouteille. 2005. Endothelial cell activation in the presence of African try- panosomes. Mol. Biochem. Parasitol. 139:41-49.
48. Godat, E., S. Chowdhury, F. Lecaille, M. Belghazi, E. Purisima, and G. Lalmanach. 2005. Inhibition of a cathepsin L-like cysteine protease by a chimeric propeptide-derived inhibitor. Biochemistry 44:10486-10493.
49. González, F., J. Izquierdo, S. Rodríguez, J. McKerrow, and E. Hansell. 2007. Dipeptidyl-alpha, beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain. Bioorg. Med. Chem. Lett. 17:6697-6700.
50. Greenwood, B., and H. Whittle. 1976. Complement activation in patients with Gambian sleeping sickness. Clin. Exp. Immunol. 24:133-138.
51. Gull, K. 2003. Host-parasite interactions and trypanosome morphogenesis: a flagellar pocketful of goodies. Curr. Opin. Microbiol. 6:365-370.
52. Haas, K., K. Taylor, N. MacHugh, J. Kreeger, and D. Estes. 2001. Enhancing effects ofanti-CD40 treatment on the immune response ofSCID-bovine mice to Trypanosoma congolense infection. J. Leukoc. Biol. 70:931-940.
53. Hamadien, M., M. Bakhiet, and R. Harris. 2000. Interferon-gamma induces secretion of trypanosome lymphocyte triggering factor via tyrosine protein kinases. Parasitology 120:281-287.
54. Holland, W., T. Do, N. Huong, N. Dung, N. Thanh, J. Vercruysse, and B. Goddeeris. 2003. The effect of Trypanosoma evansi infection on pig performance and vaccination against classical swine fever. Vet. Parasitol. 111: 115-123.
55. Holland, W., L. My, T. Dung, N. Thanh, P. Tam, J. Vercruysse, and B. Goddeeris. 2001. The influence of T. evansi infection on the immuno- responsiveness of experimentally infected water buffaloes. Vet. Parasitol. 102:225-234.
56. Huet, G., C. Richet, D. Demeyer, H. Bisiau, B. Soudan, D. Tetaert, K. Han, and P. Degand. 1992. Characterization of different proteolytic activities in Trypanosoma brucei brucei. Biochim. Biophys. Acta 1138:213-221.
57. Hunter, C., F. Jennings, J. Tierney, M. Murray, and P. Kennedy. 1992. Correlation of autoantibody titres with central nervous system pathology in experimental African trypanosomiasis. J. Neuroimmunol. 41:143-148.
58. Inal, J. 2004. Parasite interaction with host complement: beyond attack regulation. Trends Parasitol. 20:407-412.
59. Jaishankar, P., E. Hansell, D. Zhao, P. Doyle, J. McKerrow, and A. Renslo. 2008. Potency and selectivity of P2/P3-modified inhibitors of cysteine proteases from trypanosomes. Bioorg. Med. Chem. Lett. 18:624-628.
60. Jones, A., A. Faldas, A. Foucher, E. Hunt, A. Tait, J. Wastling, and C. Turner. 2006. Visualisation and analysis of proteomic data from the pro- cyclic form of Trypanosoma brucei. Proteomics 6:259-267.
61. Kirrstetter, M., C. Lerin-Lozano, H. Heintz, C. Manegold, W. Gross, and P. Lamprecht. 2004. Trypanosomiasis in a woman from Cameroon mimicking systemic lupus erythematosus. Dtsch. Med. Wochenschr. 129:1315-1317.
62. Kissinger, J. 2006. A tale ofthree genomes: the kinetoplastids have arrived. Trends Parasitol. 22:240-243.
63. Knowles, G., S. Black, and D. Whitelaw. 1987. Peptidase in the plasma of mice infected with Trypanosoma brucei brucei. Parasitology 95:291-300.
64. Lalmanach, G., A. Boulangé, C. Serveau, F. Lecaille, J. Scharfstein, F. Gauthier, and E. Authiaé. 2002. Congopain from Trypanosoma congolense: drug target and vaccine candidate. Biol. Chem. 383:739-749.
65. Lee, H., S. Kelm, J. Michalski, and R. Schauer. 1990. Influence of sialic acids on the galactose-recognizing receptor of rat peritoneal macrophages. Biol. Chem. Hoppe Seyler 371:307-316.
66. Li, S., M. Fung, S. Reid, N. Inoue, and Z. Lun. 2007. Immunization with recombinant beta-tubulin from Trypanosoma evansi induced protection against T. evansi, T. equiperdum and T. b. brucei infection in mice. Parasite Immunol. 29:191-199.
67. Lonsdale-Eccles, J., and D. Grab. 1987. Lysosomal and non-lysosomal peptidyl hydrolases of the bloodstream forms of Trypanosoma brucei brucei. Eur. J. Biochem. 169:467-475.
68. Lonsdale-Eccles, J., and D. Grab. 2002. Trypanosome hydrolases and the blood-brain barrier. Trends Parasitol. 18:17-19.
69. Lonsdale-Eccles, J., G. Mpimbaza, Z. Nkhungulu, J. Olobo, L. Smith, O. Tosomba, and D. Grab. 1995. Trypanosomatid cysteine protease activity may be enhanced by a kininogen-like moiety from host serum. Biochem. J. 305:549-556.
70. + T cell death by apoptosis in experimental Chagas' disease. J. Immunol. 154:744-752.
71. Lopes, M., and G. DosReis. 1995. Apoptosis as a cause of T-cell unre- sponsiveness in experimental Chagas' disease. Braz J. Med. Biol. Res. 28:913-918.
72. + T-cell death by the T-cell receptor- CD3 pathway and not by the CD69 or Ly-6 activation pathway. Infect. Immun. 64:1559-1564.
73. Lopes, M., M. Nunes, A. Henriques-Pons, N. Giese, H. R. Morse, W. Davidson, T. Arauajo-Jorge, and G. DosReis. 1999. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response. Eur. J. Immunol. 29:81-89.
74. Lubega, G., D. Byarugaba, and R. Prichard. 2002. Immunization with a tubulin-rich preparation from Trypanosoma brucei confers broad protection against African trypanosomosis. Exp. Parasitol. 102:9-22.
75. Mabbott, N., and J. Sternberg. 1995. Bone marrow nitric oxide production and development of anemia in Trypanosoma brucei-infected mice. Infect. Immun. 63:1563-1566.
76. Machado, A., J. Cardoso, C. Claser, M. Rodrigues, R. Gazzinelli, and O. Bruna-Romero. 2006. Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenovi- ruses encoding amastigote surface protein-2 and trans-sialidase. Hum. Gene Ther. 17:898-908.
77. Mackenzie, P., W. Boyt, V. Nesham, and E. Pirie. 1978. The aetiology and significance of the phagocytosis of erythrocytes and leucocytes in sheep infected with Trypanosoma congolense (Broden, 1904). Res. Vet. Sci. 24: 4-7.
78. Magez, S., R. Lucas, A. Darji, E. Songa, R. Hamers, and P. De Baetselier. 1993. Murine tumour necrosis factor plays a protective role during the initial phase of the experimental infection with Trypanosoma brucei brucei. Parasite Immunol. 15:635-641.
79. Magez, S., B. Stijlemans, T. Baral, and P. De Baetselier. 2002. VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology. Microbes Infect. 4:999-1006.
80. Magez, S., B. Stijlemans, M. Radwanska, E. Pays, M. Ferguson, and P. De Baetselier. 1998. The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. J. Immunol. 160:1949-1956.
81. Magez, S., C. Truyens, M. Merimi, M. Radwanska, B. Stijlemans, P. Brouc- kaert, F. Brombacher, E. Pays, and P. De Baetselier. 2004. P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis. J. Infect. Dis. 189:527-539.
82. Mallari, J., A. Shelat, T. Obrien, C. Caffrey, A. Kosinski, M. Connelly, M. Harbut, D. Greenbaum, J. McKerrow, and R. Guy. 2008. Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatB. J. Med. Chem. 51:545-552.
83. Mansfield, J., S. Craig, and G. Stelzer. 1976. Lymphocyte function in experimental African trypanosomiasis: mitogenic effects of trypanosome extracts in vitro. Infect. Immun. 14:976-981.
84. Mansfield, J., and D. Paulnock. 2005. Regulation of innate and acquired immunity in African trypanosomiasis. Parasite Immunol. 27:361-371.
85. Marañón, C., L. Planelles, C. Alonso, and M. López. 2000. HSP70 from Trypanosoma cruzi is endowed with specific cell proliferation potential leading to apoptosis. Int. Immunol. 12:1685-1693.
86. Marcondes, M., P. Borelli, N. Yoshida, and M. Russo. 2000. Acute Trypanosoma cruzi infection is associated with anemia, thrombocytopenia, leukopenia, and bone marrow hypoplasia: reversal by nifurtimox treatment. Microbes Infect. 2:347-352.
87. Masocha, W., M. Rottenberg, and K. Kristensson. 2007. Migration of African trypanosomes across the blood-brain barrier. Physiol. Behav. 92: 110-114.
88. Masocha, W., M. Rottenberg, and K. Kristensson. 2006. Minocycline impedes African trypanosome invasion of the brain in a murine model. Antimicrob. Agents Chemother. 50:1798-1804.
89. Maxie, M., G. Losos, and H. Tabel. 1979. Experimental bovine trypanoso- miasis (Trypanosoma vivax and T. congolense). I. Symptomatology and clinical pathology. Tropenmed. Parasitol. 30:274-282.
90. Mbawa, Z., I. Gumm, E. Shaw, and J. Lonsdale-Eccles. 1992. Characterisation of a cysteine protease from bloodstream forms of Trypanosoma congolense. Eur. J. Biochem. 204:371-379.
91. McKerrow, J., C. Caffrey, B. Kelly, P. Loke, and M. Sajid. 2006. Proteases in parasitic diseases. Annu. Rev. Pathol. 1:497-536.
92. McKerrow, J., J. Engel, and C. Caffrey. 1999. Cysteine protease inhibitors as chemotherapy for parasitic infections. Bioorg. Med. Chem. 7:639-644.
93. Minoprio, P. 2001. Parasite polyclonal activators: new targets for vaccina-tion approaches? Int. J. Parasitol. 31:588-591.
94. + cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells. Eur. J. Immunol. 36:1474-1485.
95. Morty, R., E. Authiaé, L. Troeberg, J. Lonsdale-Eccles, and T. Coetzer. 1999. Purification and characterisation of a trypsin-like serine oligopeptidase from Trypanosoma congolense. Mol. Biochem. Parasitol. 102:145-155.
96. Morty, R., P. Bulau, R. Pellé, S. Wilk, and K. Abe. 2006. Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts. Biochem. J. 394:635-645.
97. Morty, R., J. Lonsdale-Eccles, R. Mentele, E. Auerswald, and T. Coetzer. 2001. Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity. Infect. Immun. 69:2757-2761.
98. Morty, R., J. Lonsdale-Eccles, J. Morehead, E. Caler, R. Mentele, E. Auer- swald, T. Coetzer, N. Andrews, and B. Burleigh. 1999. Oligopeptidase B from Trypanosoma brucei, a new member of an emerging subgroup of serine oligopeptidases. J. Biol. Chem. 274:26149-26156.
99. Morty, R., R. Pellae, I. Vadaasz, G. Uzcanga, W. Seeger, and J. Bubis. 2005. Oligopeptidase B from Trypanosoma evansi. A parasite peptidase that inactivates atrial natriuretic factor in the bloodstream of infected hosts. J. Biol. Chem. 280:10925-10937.
100. Morty, R., L. Troeberg, J. Powers, S. Ono, J. Lonsdale-Eccles, and T. Coetzer. 2000. Characterisation of the antitrypanosomal activity of peptidyl alpha-aminoalkyl phosphonate diphenyl esters. Biochem. Pharmacol. 60: 1497-1504.
101. Morty, R., I. Vadász, P. Bulau, V. Dive, V. Oliveira, W. Seeger, and L. Juliano. 2005. Tropolysin, a new oligopeptidase from African trypano- somes. Biochemistry 44:14658-14669.
102. Mucci, J., M. Risso, M. Leguizamón, A. Frasch, and O. Campetella. 2006. The trans-sialidase from Trypanosoma cruzi triggers apoptosis bytarget cell sialylation. Cell Microbiol. 8:1086-1095.
103. Murray, M., and W. Morrison. 1979. Non-specific induction of increased resistance in mice to Trypanosoma congolense and Trypanosoma brucei by immunostimulants. Parasitology 79:349-366.
104. Naessens, J. 2006. Bovine trypanotolerance: a natural ability to prevent severe anaemia and haemophagocytic syndrome? Int. J. Parasitol. 36:521-528.
105. Naessens, J., H. Kitani, Y. Nakamura, Y. Yagi, K. Sekikawa, and F. Iraqi. 2005. TNF-alpha mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection. Clin. Exp. Immunol. 139:405-410.
106. Namangala, B., C. Sugimoto, and N. Inoue. 2007. Effects of exogenous transforming growth factor beta on Trypanosoma congolense infection in mice. Infect. Immun. 75:1878-1885.
107. Ndung'u, J., N. Wright, F. Jennings, and M. Murray. 1992. Changes in atrial natriuretic factor and plasma renin activity in dogs infected with Trypanosoma brucei. Parasitol. Res. 78:553-556.
108. Nielsen, K., and J. Sheppard. 1977. Activation of complement by trypano- somes. Experientia 33:769-771.
109. Nielsen, K., J. Sheppard, W. Holmes, and I. Tizard. 1978. Experimental bovine trypanosomiasis. Changes in serum immunoglobulins, complement and complement components in infected animals. Immunology 35:817-826.
110. Nielsen, K., J. Sheppard, I. Tizard, and W. Holmes. 1978. Complement activating factor(s) of Trypanosoma lewisi: some physiochemical character-istics of the active components. Can. J. Comp. Med. 42:74-79.
111. Nikolskaia, O., A. de Lima, Y. Kim, J. Lonsdale-Eccles, T. Fukuma, J. Scharfstein, and D. Grab. 2006. Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine pro-tease. J. Clin. Investig. 116:2739-2747.
112. Nishimura, K., K. Hamashita, Y. Okamoto, F. Kawahara, H. Ihara, S. Kozaki, Y. Ohnishi, and S. Yamasaki. 2004. Differential effects of interferon- gamma on production of trypanosome-derived lymphocyte-triggering factor by Trypanosoma brucei gambiense and Trypanosoma brucei brucei. J. Para-sitol. 90:740-745.
113. Nishimura, K., K. Shima, M. Asakura, Y. Ohnishi, and S. Yamasaki. 2005. Effects of heparin administration on Trypanosoma brucei gambiense infec-tion in rats. J. Parasitol. 91:219-222.
114. Noel, W., G. Hassanzadeh, G. Raes, B. Namangala, I. Daems, L. Brys, F. Brombacher, P. Baetselier, and A. Beschin. 2002. Infection stage-depen-dent modulation of macrophage activation in Trypanosoma congolense- resistant and -susceptible mice. Infect. Immun. 70:6180-6187.
115. Nok, A., H. Nzelibe, and S. Yako. 2003. Trypanosoma evansi sialidase: surface localization, properties and hydrolysis of ghost red blood cells and brain cells-implications in trypanosomiasis. Z Naturforsch. C 58:594-601.
116. Nok, A., and E. Balogun. 2003. A bloodstream Trypanosoma congolense sialidase could be involved in anemia during experimental trypanosomiasis. J. Biochem. 133:725-730.
117. Nwagwu, M., D. Okenu, T. Olusi, and R. Molokwu. 1988. Trypanosoma brucei releases proteases extracellularly. Trans. R. Soc. Trop. Med. Hyg. 82:577.
118. Oka, M., and Y. Ito. 1987. Polyclonal B-cell-activating factors produced by spleen cells of mice stimulated with a cell homogenate of Trypanosoma gambiense. Infect. Immun. 55:3162-3167.
119. Okenu, D., K. Opara, R. Nwuba, and M. Nwagwu. 1999. Purification and characterisation of an extracellularly released protease of Trypanosoma brucei. Parasitol. Res. 85:424-428.
120. + T cells: a trypanosome-released factor triggers interferon- gamma production that stimulates parasite growth. Eur. J. Immunol. 21: 2447-2454.
121. Olsson, T., M. Bakhiet, B. Hojeberg, A. Ljungdahl, C. Edlund, G. Anders-son, H. Ekre, W. Fung-Leung, T. Mak, and H. Wigzell. 1993. CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell 72:715-727.
122. Omer, F., and E. Riley. 1998. Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J. Exp. Med. 188:39-48.
123. + T cells and monocytes on the proliferative responses of peripheral blood leucocytes from Trypanosoma evansi-infected sheep. Vet. Parasitol. 92:25-35.
124. Onah, D., and D. Wakelin. 2000. Murine model study of the practical implication of trypanosome-induced immunosuppression in vaccine-based disease control programmes. Vet. Immunol. Immunopathol. 74:271-284.
125. Parsons, M., E. Worthey, P. Ward, and J. Mottram. 2005. Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi. BMC Genomics 6:127.
126. Pays, E. 2006. The variant surface glycoprotein as a tool for adaptation in African trypanosomes. Microbes Infect. 8:930-937.
127. Playfair, J., J. Taverne, C. Bate, and J. de Souza. 1990. The malaria vaccine: anti-parasite or anti-disease? Immunol. Today 11:25-27.
128. Radwanska, M., P. Guirnalda, C. De Trez, B. Ryffel, S. Black, and S. Magez. 2008. Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine- induced memory responses. PLoS Pathog. 4:e1000078.
129. Ralston, K., and K. Hill. 2006. Trypanin, a component of the flagellar dynein regulatory complex, is essential in bloodstream form African try- panosomes. PLoS Pathog. 2:e101.
130. Ralston, K., A. Lerner, D. Diener, and K. Hill. 2006. Flagellar motility contributes to cytokinesis in Trypanosoma brucei and is modulated by an evolutionarily conserved dynein regulatory system. Eukaryot. Cell 5:696-711.
131. Rasooly, R., and N. Balaban. 2002. Structure of p15 trypanosome micro- tubule associated protein. Parasitol. Res. 88:1034-1039.
132. Rasooly, R., and N. Balaban. 2004. Trypanosome microtubule-associated protein p15 as a vaccine for the prevention of African sleeping sickness. Vaccine 22:1007-1015.
133. Reina-San-Martin, B., W. Degrave, C. Rougeot, A. Cosson, N. Chamond, A. Cordeiro-Da-Silva, M. Arala-Chaves, A. Coutinho, and P. Minoprio. 2000. A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat. Med. 6:890-897.
134. Robertson, C., M. North, B. Lockwood, and G. Coombs. 1990. Analysis of the proteinases of Trypanosoma brucei. J. Gen. Microbiol. 136:921-925.
135. Rosenthal, P. 1999. Proteases of protozoan parasites. Adv. Parasitol. 43: 105-159.
136. Rurangirwa, F. R., A. J. Musoke, V. M. Nantulya, and H. Tabel. 1983. Immune depression in bovine trypanosomiasis-effects of acute and chronic Trypanosoma congolense and chronic Trypanosoma vivax infections on antibody response to Brucella abortus vaccine. Parasite Immunol. 5:267-276.
137. Rurangirwa, F. R., H. Tabel, G. Losos, and I. R. Tizard. 1980. Hemolytic complement and serum C-3 levels in Zebu cattle infected with Trypanosoma congolense and Trypanosoma vivax and the effect of trypanocidal treatment. Infect. Immun. 27:832-836.
138. Sacco, R., M. Hagen, J. Donelson, and R. Lynch. 1994. B lymphocytes of mice display an aberrant activation phenotype and are cell cycle arrested in G0/G1A during acute infection with Trypanosoma brucei. J. Immunol. 153: 1714-1723.
139. Sacks, D., G. Bancroft, W. Evans, and B. Askonas. 1982. Incubation of trypanosome-derived mitogenic and immunosuppressive products with peritoneal macrophages allows recovery of biological activities from soluble parasite fractions. Infect. Immun. 36:160-168.
140. Santos, C., G. Coombs, A. Lima, and J. Mottram. 2007. Role of the Trypanosoma brucei natural cysteine peptidase inhibitor ICP in differenti-ation and virulence. Mol. Microbiol. 66:991-1002.
141. Serveau, C., A. Boulange, F. Lecaille, F. Gauthier, E. Authie, and G. Lal- manach. 2003. Procongopain from Trypanosoma congolense is processed at basic pH: an unusual feature among cathepsin L-like cysteine proteases. Biol. Chem. 384:921-927.
142. Sheppard, J., K. Nielsen, I. Tizard, and W. Holmes. 1978. Direct activation of complement by trypanosomes. J. Parasitol. 64:544-546.
143. Shugaba, A., I. Umar, J. Omage, N. Ibrahim, J. Andrews, A. Ukoha, D. Saror, and K. Esievo. 1994. Biochemical differences (O-acetyl and glycolyl groups) in erythrocyte surface sialic acids of trypanotolerant N'dama and trypanosusceptible Zebu cattle. J. Comp. Pathol. 110:91-95.
144. Soudan, B., D. Tetaert, M. Hublart, A. Racadot, D. Croix, and A. Boersma. 1993. Experimental "chronic" African trypanosomiasis: endocrine dysfunc-tions generated by parasitic components released during the tryptanolytic phase in rats. Exp. Clin. Endocrinol. 101:166-172.
145. Stijlemans, B., T. Baral, M. Guilliams, L. Brys, J. Korf, M. Drennan, J. Van Den Abbeele, P. De Baetselier, and S. Magez. 2007. A glycosylphosphati- dylinositol-based treatment alleviates trypanosomiasis- associated immuno- pathology. J. Immunol. 179:4003-4014.
146. Stijlemans, B., M. Guilliams, G. Raes, A. Beschin, S. Magez, and P. De Baetselier. 2007. African trypanosomosis: from immune escape and immu- nopathology to immune intervention. Vet. Parasitol. 148:3-13.
147. Stiles, J., J. Meade, Z. Kucerova, D. Lyn, W. Thompson, Z. Zakeri, and J. Whittaker. 2001. Trypanosoma brucei infection induces apoptosis and up- regulates neuroleukin expression in the cerebellum. Ann. Trop. Med. Para- sitol. 95:797-810.
148. Stiles, J., J. Whittaker, B. Sarfo, W. Thompson, M. Powell, and V. Bond. 2004. Trypanosome apoptotic factor mediates apoptosis in human brain vascular endothelial cells. Mol. Biochem. Parasitol. 133:229-240.
149. Suliman, H., L. Logan-Henfrey, P. Majiwa, O. Ole-Moiyoi, and B. Feldman. 1999. Analysis of erythropoietin and erythropoietin receptor genes expres-sion in cattle during acute infection with Trypanosoma congolense. Exp. Hematol 27:37-45.
150. Suzuki, T., Y. Ueta, N. Inoue, X. Xuan, H. Saitoh, and H. Suzuki. 2006. Beneficial effect of erythropoietin administration on murine infection with Trypanosoma congolense. Am. J. Trop. Med. Hyg. 74:1020-1025.
151. Tizard, I., K. Nielsen, J. Seed, and J. Hall. 1978. Biologically active products from African Trypanosomes. Microbiol. Rev. 42:664-681.
152. Troeberg, L., R. Pike, R. Morty, R. Berry, T. Coetzer, and J. Lonsdale- Eccles. 1996. Proteases from Trypanosoma brucei brucei. Purification, char-acterisation and interactions with host regulatory molecules. Eur. J. Bio - chem. 238:728-736.
153. Uche, U. E., and T. W. Jones. 1992. Complement (C3) levels and activation in rabbits experimentally infected with Trypanosoma evansi. Ann. Trop. Med. Parasitol. 86:475-480.
154. Vaidya, T., M. Bakhiet, K. Hill, T. Olsson, K. Kristensson, and J. Donelson. 1997. The gene for a T lymphocyte triggering factor from African trypano- somes. J. Exp. Med. 186:433-438.
155. Valli, V., C. Forsberg, and B. McSherry. 1978. The pathogenesis of Trypanosoma congolense infection in calves. II. Anemia and erythroid response. Vet. Pathol. 15:732-745.
156. van Velthuysen, M., J. Bruijn, E. van Leer, and G. Fleuren. 1992. Patho- genesis of trypanosomiasis-induced glomerulonephritis in mice. Nephrol. Dial. Transplant. 7:507-515.
157. Vicik, R., V. Hoerr, M. Glaser, M. Schultheis, E. Hansell, J. McKerrow, U. Holzgrabe, C. Caffrey, A. Ponte-Sucre, H. Moll, A. Stich, and T. Schirmeister. 2006. Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents. Bioorg. Med. Chem. Lett. 16:2753-2757.
158. Vincendeau, P., and B. Bouteille. 2006. Immunology and immunopathology of African trypanosomiasis. An. Acad. Bras. Cienc. 78:645-665.
159. Vray, B., S. Hartmann, and J. Hoebeke. 2002. Immunomodulatory proper-ties of cystatins. Cell Mol. Life Sci. 59:1503-1512.
160. Zambrano-Villa, S., D. Rosales-Borjas, J. Carrero, and L. Ortiz-Ortiz. 2002. How protozoan parasites evade the immune response. Trends Para- sitol. 18:272-278.
161. Zapata-Estrella, H., C. Hummel-Newell, G. Sanchez-Burgos, J. Escobedo- Ortegon, M. Ramirez-Sierra, A. Arjona-Torres, and E. Dumonteil. 2006. Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice. Immunol. Lett. 103:186-191.
162. Zuiiiga, E., C. Motran, C. Montes, F. Diaz, J. Bocco, and A. Gruppi. 2000. Trypanosoma cruzi-induced immunosuppression: B cells undergo sponta-neous apoptosis and lipopolysaccharide (LPS) arrests their proliferation during acute infection. Clin. Exp. Immunol. 119:507-515.
163. Zuniiga, E., C. Motran, C. Montes, H. Yagita, and A. Gruppi. 2002. Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas/Fas ligand-mediated fratricide. J. Immunol. 168:3965-3973.